Chemical synthesis of 2,6-bis(1-imidazole-2-yl)-4-chloropyridine highlights new ligand possibilities.
On the basis of helidamic acid, 4-chloropyridine-2,6-dicarboxamide and 4-chloropyridine-2,6-dicarbonitrile were synthesized sequentially, the interaction of which with diethyl acetal aminoacetaldehyde led to 2,6-bis(1-imidazole-2-yl)-4-chloropyridine, a tridentate ligand.
No takes yet. Share an insight, caveat, or question.
I. A. OS’KINA (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: